Chromosomal instability promotes cell migration and invasion via EFEMP1 secretion into extracellular vesicles.
Triple-negative breast cancer (TNBC) is characterised by high rates of chromosomal instability (CIN) and rewired intercellular communication driven by both soluble factors and extracellular vesicles (
APA
Zheng S, Tian R, et al. (2026). Chromosomal instability promotes cell migration and invasion via EFEMP1 secretion into extracellular vesicles.. The EMBO journal. https://doi.org/10.1038/s44318-026-00766-4
MLA
Zheng S, et al.. "Chromosomal instability promotes cell migration and invasion via EFEMP1 secretion into extracellular vesicles.." The EMBO journal, 2026.
PMID
41974939
Abstract
Triple-negative breast cancer (TNBC) is characterised by high rates of chromosomal instability (CIN) and rewired intercellular communication driven by both soluble factors and extracellular vesicles (EVs). To assess how CIN might affect EV-mediated signalling in TNBC, we studied the EV landscape of TNBC cell lines with induced CIN. We find that CIN leads to increased secretion of EVs and that these EVs promote cell migration of recipient cells. EVs are enriched for extracellular matrix (ECM) proteins, including EFEMP1. Indeed, modulation of EFEMP1 levels in EVs significantly alters migration behaviour of EV-treated cells. We show that EFEMP1 expression is regulated by STAT1, that EVs from STAT1-deficient cells no longer promote migration, and that this can be rescued by overexpression of EFEMP1 in STAT1-null cells. Xenografting TNBC cells with EFEMP1-enriched cells promotes migration in zebrafish embryos, suggesting that EFEMP1 expression is a factor that promotes metastasis. Together, our results identify a CIN-associated EV program in triple-negative breast cancer and highlight EFEMP1 as a potential therapeutic target to impair EV-driven tumour cell migration.
같은 제1저자의 인용 많은 논문 (5)
- Temporal radiomics for non-invasive preoperative prediction of pathologic complete response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer.
- EASDnet: Empowering human-centered evidence-based medicine through an evidence and attention-based spatial disparity network for discriminative colorectal cancer histopathological screening and attribution.
- CAR immune cell therapy strategies and advances for lung cancer.
- Phosphoenolpyruvate carboxykinase 2 as a prognostic biomarker: expression and clinical significance in Group 3 and Group 4 medulloblastoma.
- Dissector-Assisted Liposuction for Dorsocervical Fibrolipodystrophy (Buffalo Hump): Results from 57 Patients.